{"entity":{"id":"nct06867705","kind":"trial","name":"Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only","aka":[],"tldr":"A phase 3 trial of Resilience PRO in advanced solid tumours, run by Resilience, now recruiting.","summary":"Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only is a phase 3 interventional study registered as NCT06867705 by Resilience, with 1458 participants planned, started 2025-04-01 and due to reach its primary completion in 2027-01. Interventions recorded: Resilience PRO.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06867705","url":"https://clinicaltrials.gov/study/NCT06867705"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06867705","phase":"3","setting":"Digital Monitoring With Patient-Reported Outcomes in Cancer Care: A Randomized Controlled Trial RC - 102 (Resilience Care - 102)","sponsor":"Resilience","participation":[{"nct":"NCT06867705","source":"https://clinicaltrials.gov/study/NCT06867705","fetchedAt":"2026-10-07T16:55:12.940Z","studySha256":"05598c876bcc7120e5675d4aa32ba265c74da413810687258ebd3e062dbbeb86","overallStatus":"RECRUITING","lastUpdatePosted":"2026-04-03","leadSponsor":"Resilience","collaboratorCount":2,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":1458,"enrolmentType":"ESTIMATED","siteCount":36,"recruitingSiteCount":36,"countries":["France","Germany"]}],"started":"2025-04-01","startedType":"actual","enrolled":1458,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06867705/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}